Kathy Giusti - Founder of MMRF

About Kathy Giusti

kathy-giusti-founder-MMRF

Follow Kathy on Social Media
fbsigtwitsiglisigyousiginstasig

Kathy Giusti, a multiple myeloma patient, is the Founder of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). She is the Henry & Allison McCance Family Senior Fellow at Harvard Business School, where she serves as Faculty Co-Chair of HBS Kraft Precision Medicine Accelerator, a $20M program endowed by Robert Kraft and the Kraft Family Foundation. She currently serves on the MMRF Board of Directors. Giusti has more than two decades of experience in the pharmaceutical industry, previously holding senior positions at G.D. Searle and Merck.

Since founding the MMRF in 1998, Giusti has become a widely respected leader in establishing innovative, collaborative research models in the areas of tissue banking, genomics, and clinical trials. These models are dramatically accelerating the pace at which lifesaving treatments are brought to patients and are building an end-to-end solution in precision medicine. Today, Giusti is recognized as a pioneer of precision medicine, a champion of open-access data sharing, and a strong advocate for patient engagement.

In 2016, Giusti was named Faculty Co-Chair of the Harvard Business School (HBS) Kraft Precision Medicine Accelerator. Under Giusti’s leadership, the HBS Kraft Precision Medicine Accelerator convenes best-in-class leaders from science, business and technology to identify and solve challenges slowing the advancement of precision medicine. The HBS Kraft PM Accelerator disseminates best practices and models to overcome these challenges, and, ultimately, enables faster adoption of high-impact innovations.

Giusti has earned several prestigious awards and recognitions, including being named 1 of 3 Top Business Leaders Disrupting Medicine by Fortune Magazine and #19 on Fortune’s World’s 50 Greatest Leaders list. Giusti was also named one of the world’s 100 Most Influential People by TIME magazine. In 2017, she received PRIMO’s Exceptional Women in Oncology award. In addition, she received the Open Science Champion of Change award by the White House and has been honored with the American Association for Cancer Research Centennial Medal for Distinguished Public Service and the Healthcare Businesswomen’s Association’s Woman of the Year Award.

Giusti served on President Obama’s 2015 Precision Medicine Initiative Working Group and continues to act as an active advisor to the Obama PMI (“All of Us”) and Vice President Biden’s Cancer Moonshot program. She currently is a member of the Harvard Business School (HBS) Health Advisory Board and has previously served on the President’s Council of Advisors on Science and Technology (PCAST), National Cancer Advisory Board (NCAB), and the National Cancer Policy Board (NCBP).

Giusti has been featured on the Today Show, NBC Nightly News, CBS Evening News, Fox News, CNN, and Bloomberg. Her efforts have also been profiled by Fortune, The Wall Street Journal, Harvard Business Review, The New York Times, Forbes, The New Yorker, WIRED, and Fast Company.

Giusti received her MBA in general management from Harvard Business School. She holds an honorary Doctorate from the University of Vermont.

Learn more about Kathy:

Widespread Recognition
Kathy’s work has garnered a number of prestigious awards including:

Social Media
Follow Kathy on Twitter
Follow Kathy on Facebook
Follow Kathy on Instagram
Follow Kathy on LinkedIn

Visit KathyGiusti.com

Read about Kathy Giusti’s transformative approach to cancer research:

“What Precision Medicine Can Learn from the NFL” by
Harvard Business School Kraft Precision Medicine Accelerator Co-Chairs Kathy Giusti & Richard G. Hamermesh

Forbes, April 2017

Interview with Kathy Giusti, Founder of the Multiple Myeloma Research Foundation and Co-Chair of the HBS Kraft Precision Medicine Accelerator
Precision Medicine World Conference Online, April 2017

Kathy Giusti featured in Lifestyles Magazine: “Patient Power”
Lifestyles Magazine, March 2017

The power — and the fear — of knowing your cancer genome by Kathy Giusti
STAT, February 2017

“What Cancer Researchers Can Learn from Direct-to-Consumer Companies” by
Harvard Business School Kraft Precision Medicine Accelerator Co-Chairs Kathy Giusti & Richard G. Hamermesh

Harvard Business Review, January 2017

Kathy Giusti Featured in STAT – “Choose the cancer center that’s right for your cancer”
STAT, December 2016

“What Shopping Has Taught Me About How We Treat Cancer” by Kathy Giusti
The Huffington Post, November 2016

“Kathy Giusti: Sharing Life Lessons From a Death Sentence” – Adam Bryant, Corner Office
New York Times, October 2016

“A woman who was given 3 years to live in 1996 explains how her ‘death sentence’ made her one of the world’s best leaders”
Business Insider, October 2016

“Precision Medicine for All” by Kathy Giusti
MMRF, February 2016

“Kathy Giusti: The businesswoman who took on her own cancer”
STAT, February 2016

Fortune Profiles MMRF Founder Kathy Giusti as Cancer Warrior
Fortune, August 2014

Kathy Giusti Named to PharmaVOICE 100 List
PharmaVOICE, August 2014

Kathy Giusti #19 on List of “The World’s 50 Greatest Leaders”
Fortune, March 2014

MMRF Featured in Fast Company as “Savvy Renegade…Saving Lives”
Fast Company, April 2013

Kathy Giusti Named to the 2011 TIME 100
Time Magazine April 2011

Watch Kathy Giusti speak about the innovative model of the MMRF:

Kathy Giusti at PMWC 2017: The Value of Data Sharing
PMWC 2017, March 2017

Kathy Giusti Interviewed on Wall Street Journal Live 
WSJ Live
WSJ Live, July 2014

CNN International’s Quest Means Business Interview with Kathy Giusti
WSJ Live, April 2014

A Mission With Precision: Kathy Giusti’s Ambitious Quest To Cure Multiple Myeloma
Forbes, December 2013

How Sharing of Data Can Improve Cancer Research
MSNBC, September 2013

MMRF Founder and CEO on Huffington Post Live
Huffington Post Live, June 2013

Healthcare Entrepreneur Kathy Giusti Addresses MBA Class of 2011
Harvard Business School Class Day, May 2011

Read more articles authored by Kathy Giusti:

Cancer Research: Not a One-Size-Fits-All Approach
WIRED, August 2014

The Multiple Myeloma Research Foundation’s evolving focus on drug R&D
Nature Biotechnology, July 2012